We found increased AT1R and ETAR antibodies in COVID-19 patients compared to controls, but surprisingly and in contrast with previous studies, we did not find increased titers in unfavorable compared to favorable COVID-19 disease (1–3). The gene discussed is EDNRA; the disease is COVID-19.